NEW YORK, July 11, 2018 /PRNewswire/ --
According to a research report provided by Marijuana Business Daily, cannabis retail sales continue to grow year-over-year as
new markets appear and more states legalize medical and recreational cannabis products. Sales in 2018 are expected to increase by
approximately 50% compared to 2017. Sales value is on track to reach USD 8 Billion - USD 10 Billion
by the end of this year. The report also indicates that by 2022, annual retail cannabis sales in the
United States could surpass the USD 20 Billion mark, a 200% increase from 2017. As for the
economic impact that the growing industry is set to have, the data predicts an estimated USD 28 Billion -
USD 34 Billion of economic impact in 2018. Crop Infrastructure Corp. (OTC: CRXPF), Auxly Cannabis Group Inc. (OTC:
CBWTF), United Cannabis Corporation (OTC: CNAB), GB Sciences Inc. (OTC: GBLX), mCig Inc. (OTC: MCIG)
On June 19th, 2018, Canada passed a nationwide legalization of
recreational cannabis usage, following Uruguay to become the second nation to do so. According
to the New York Times, Tony Dean, the Senator who sponsored the bill
in the Chamber, said that, "We've just witnessed a historic vote for Canada, the end of 90 years
of prohibition. Now we can start to tackle some of the harms of cannabis." Mr. Dean continued, "We can start to be proactive in
public education. We'll see the end of criminalization and we can start addressing Canada's
USD 7 Billion illegal markets."
Crop Infrastructure Corp. (OTC: CRXPF) is also listed on the Canadian Securities Exchange under the ticker (CSE:
CROP). Earlier today the company announced breaking news that, its 30% owned Italy Joint Venture partner "XHemplar Italia"
has planted 25 acres or 1,089,000 square feet of high CBD "Cannabis Light" in North Eastern Italy. This represents over a 100%
increase on the previously announced capacity announced in press release dated June 27th 2018.
The Joint Venture's resulting high CBD "Cannabis Light" will be processed and sold into international CBD markets under white
label, the venture's house name XHemplar and Crop brands Tiffany CBD and Hempire Italia. The company will also use the production
to infuse its recently announced therapeutic and cosmetic product lines, licensed from The Yield Growth Corp., which transaction
is now complete giving Crop exclusive rights in Italy to over 55 wellness products.
According to Arcview Market Research and its partner, BDS Analytics, government-subsidized health care spending (worldwide
market at $1.3-trillion) is expected to make Europe among the
fastest growing and largest medical cannabis markets in the world. Arcview expects Italy to be
the second largest cannabis market in Europe by 2027 with $1.2
billion in sales.
CROP Infrastructure Director & CEO Michael Yorke states: "The company is extremely
encouraged by the fast pace with which the team at XHemplar has commenced production in Italy.
CROPs portfolio of cannabis infrastructure assets now includes cultivation properties in California, Washington State, Nevada,
Italy and joint ventures on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of 15 Cannabis brands and also
has US and Italian distribution rights to a line of over 55 cannabis topical products. Management will continue to aggressively
pursue new world-wide opportunities and expand its portfolio of tenant growers and infrastructure assets in strategic licensed
jurisdictions."
XHemplar Chairman and CROP Infrastructure VP of M&A, EMEA Andrea Castiglione states: "This is a great start for the
company in Italy. We are pleased by how quickly our joint venture team has worked together to
begin this initial production."
About XHemplar: Hemplar is a joint venture between CROP Infrastructure Stratto, LLC and the AnCaPa SRL of the prominent
Castiglione family. This endeavor will be led locally by the CEO of XHemplar Giuseppe Castiglione who has spent the past 30 years
in National and International politics roles ranging from Vice President of Sicily - with
special delegation on Agriculture and Industrial development - to member of the European Parliament - where he acted as head
supervisor of the European Wine Reform - to Vice Minister of Agriculture and Forestry Politics for the Italian central government
in three consecutive legislatures. As an agricultural company XHemplar enjoys substantially lower tax rates with 4% VAT in
Italy from which the company will greatly benefit in these early stages.
Auxly Cannabis Group Inc. (OTCQX: CBWTF) is a collective of entrepreneurs with a passion for the cannabis industry
past, present and future. Recently, the Company provided the following construction development update on the joint venture with
FV Pharma Inc., a wholly-owned subsidiary of FSD Pharma Inc., at the former Kraft food-production facility located in
Cobourg, Ontario. The Facility hosts an initial 620,000 sq. ft. of building space, a portion of
which is currently licensed for cultivation, pursuant to the Access to Cannabis for Medical Purposes Regulations and can support
additional expansion capacity of approximately 3,800,000 sq. ft. on the existing property, pending completion of all phases of
the project. Chuck Rifici, Chairman and Chief Executive Officer of Auxly commented, "As Canada
moves towards legalization of adult-use cannabis and meaningfully expands its medical cannabis program, Auxly remains committed
to cultivating quality cannabis flower at a meaningful scale. Cultivating cannabis requires a significant amount of energy in
order to ensure proper growing conditions and this is one of the main contributors to overall operations costs. The technological
advancements to be implemented at the facility provide us with flexibility in terms of securing a stable supply of energy while
maintaining competitive operating costs relative to the rest of the industry."
United Cannabis Corporation (OTCQB: CNAB) is a biotechnology company dedicated to the development of phyto-therapeutic
based products supported by patented technologies for the pharmaceutical, medical, and industrial hemp markets. The Company
recently announced that the South African Patent Office has declared effective the Company's patent application based upon
PCT/US2015/056635, and pursuant to the Patent Cooperation Treaty (PCT), for "Cannabis Extracts and Methods of Preparing and Using
Same." The processes included in the filing are integral to the Company's branded products, including the Prana Bio Nutrient
Medicinals line, and comprise the application of strain specific ratio based phytocannabinoids, cannabinoids, chemical-free
extractions, and the use of cannabis derived terpenes in the medical and pharmaceutical delivery methods including capsules,
sublinguals, topicals, transdermal applications, supplements, edibles, aerosol sprays, nebulizers, inhalers, aromatherapy,
suppositories, and vaporization. Earnest Blackmon, United Cannabis' Chief Executive Officer,
commented on the approval: "South Africa is one of many markets where medical marijuana is
viewed favorably, and we look forward to establishing a strong presence there, and making our Prana products available to
qualified patients across the country. As we continue to move into new markets it's important that we protect our innovations and
the investment that we have made in product development, so we are very pleased that the South African Patent Office has approved
our patent application."
GB Sciences Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production
methods, as well as biopharmaceutical research and development. GB Sciences recently announced the filing of a new provisional
patent application on the use of cannabis-based therapies for the manipulation of cannabis-sensitive ion channels in sensory
neurons that contribute to chronic inflammatory pain conditions, peripheral neuropathy, urinary cystitis, asthma, and specific
types of hearing loss. The GB Sciences drug development team believes that these new cannabis-based treatments could well herald
the dawning of 'individualized medicines' from the cannabis plant by re-establishing balance in each individual patient's
endocannabinoid system. "Manipulating the TRP channels in sensory neurons could provide much needed relief for patients who are
suffering from chronic pain, asthma, urinary cystitis, or hearing loss," explains Dr. Andrea
Small-Howard, Chief Science Officer of GB Sciences. "The ability to use specific combinations of cannabinoids and
terpenoids to modulate TRP ion channels in sensory neurons could usher in the beginning of a new era of precision medicines
derived from the cannabis plant."
mCig Inc. (OTC: MCIG) is a diversified company servicing the legal cannabis, hemp, and CBD markets via its lifestyle
brands. The Company recently provided an update for its HEMP project and the new line of CBD products, soon to be hitting the
markets. "NYAcres Project growing 40 acres of Industrial Hemp- a CBD concentrated organic variety called Cherry Wine - is on target with projections to yield 55,000 pounds of flower for production of organic CBD
oil. Five fields are planted and secured on the 220-acre organic certified farm with daily maintenance and irrigation to mitigate
mother nature's whims and cross pollinated with organic honey bees to strengthen conditions for production. This summer
Hudson Valley's long hot sunny days and cool nights are ideal for growing conditions," said Chief
Executive Officer, Tessa Edick of NYAcres. "With different Company divisions getting a traction
and starting to show a real growth we finally decided to jump start our CBD division with an introduction of a new line of hemp
products, that will include natural skin cosmetics, full spectrum tinctures and probiotic pet's edibles. Today we have all the
right pieces in place together: a hemp farm run by professional farmers, experienced research and development team, led by
Arkady Uryash, MD PhD, and strong goal-oriented sales and marketing team. The big role in our
growth strategy will play online sales, where the Company will introduce its new online store but also a marketplace of CBD
products from different manufactures, long awaited project, that only now can be a success with having on board a new team of
professionals," said mCig Inc. Chief Executive Officer, Paul Rosenberg.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake
any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For Crop Infrastructure Corp. financial news dissemination and PR services,
FinancialBuzz.com expects to be compensated five thousand dollars by the company. Our fees may be
either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination
thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on
or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments
for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site
or continue to post information about any companies the information contained herein is not intended to be used as the basis for
investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is
not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for
any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other
materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of
their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance,
and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound
by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com
constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment
strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is
solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives,
other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and
legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless
of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be
reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please
visit: http://www.financialbuzz.com .
Media Contact:
info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com